Brief: Kiromic BioPharma Posts Qtrly Net Loss Per Share $0.48
13/05/2022 13:11
May 13 (Reuters) - Kiromic Biopharma Inc KRBP.O :
* KIROMIC BIOPHARMA REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS
AND RECENT CORPORATE HIGHLIGHTS
* KIROMIC BIOPHARMA INC - QTRLY NET LOSS PER SHARE $0.48
Source text for Eikon: ID:nBw2Nv7yxa
Further company coverage: KRBP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kiromic Biopharma
See all newsBrief: Kiromic Biopharma Files For Offering Up To 1 Million Units
Brief: Kiromic Biopharma Applies To List Common Stock On The NYSE American Under Symbol 'KRBP'
Brief: Kiromic Biopharma Advances Deltacel-01 Into Expansion Phase Following Safety Monitoring Committee's Unanimous Recommendation
Brief: Kiromic Biopharma Reports Favorable Results At Six Weeks From Fourth Patient In Deltacel-01 Clinical Trial
Brief: Kiromic BioPharma Adds UPMC as Fourth Deltacel-01 Clinical Trial Site